Attenuation of Semliki Forest virus neurovirulence by micrornamediated Detargeting

Journal of Virology

Volumn 87, Issue 1, 2013, Pages 335-344

  Ylösmäki, Erkko ^a   Martikainen, Miika ^b   Hinkkanen, Ari ^b   Saksela, Kalle ^a,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; MICRORNA 124; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4; ONCOLYTIC VIRUS; VIRUS VACCINE;

ALPHAVIRUS INFECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFECTION; CANCER CELL CULTURE; CONTROLLED STUDY; CORPUS CALLOSUM; DISEASE COURSE; DRUG POTENCY; FEMALE; GENETIC PROCEDURES; HUMAN; HUMAN CELL; IN VITRO STUDY; MICRORNA MEDIATED DETARGETING; MOUSE; NONHUMAN; NONSTRUCTURAL PROTEIN 3 GENE; NONSTRUCTURAL PROTEIN 4 GENE; OLIGODENDROGLIA; ONCOLYTIC VIROTHERAPY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN PROCESSING; SEMLIKI FOREST ALPHAVIRUS; SURVIVAL; VACCINATION; VIRUS ATTENUATION; VIRUS GENE; VIRUS IMMUNITY; VIRUS NEUROVIRULENCE; VIRUS REPLICATION; VIRUS TITRATION; VIRUS VIRULENCE;

ALPHAVIRUS INFECTIONS; ANIMALS; BRAIN; CELL LINE; CELL SURVIVAL; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; MICRORNAS; RNA, VIRAL; SEMLIKI FOREST VIRUS; SURVIVAL ANALYSIS; VIRAL TROPISM; VIRUS REPLICATION;

ALPHAVIRUS; ANIMALIA; MUS; RABBIT FIBROMA VIRUS; RNA VIRUSES; SEMLIKI FOREST VIRUS; SINDBIS VIRUS;

EID: 84871984467     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01940-12     Document Type: Article

References (33)

1. Bartel DP. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297.
2. Cullen BR. 2011. Viruses and microRNAs: RISCy interactions with serious consequences. Genes Dev. 25:1881-1894.
3. Croce CM. 2009. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 10:704-714.
4. Barnes D, Kunitomi M, Vignuzzi M, Saksela K, Andino R. 2008. Harnessing endogenous miRNAs to control virus tissue tropism as a strategy for developing attenuated virus vaccines. Cell Host Microbe 4:239-248.
5. Edge RE, Falls TJ, Brown CW, Lichty BD, Atkins H, Bell JC. 2008. A let-7 MicroRNA-sensitive vesicular stomatitis virus demonstrates tumorspecific replication. Mol. Ther. 16:1437-1443.
6. Hikichi M, Kidokoro M, Haraguchi T, Iba H, Shida H, Tahara H, Nakamura T. 2011. MicroRNA regulation of glycoprotein B5R in oncolytic vaccinia virus reduces viral pathogenicity without impairing its antitumor efficacy. Mol. Ther. 19:1107-1115.
7. Kelly EJ, Hadac EM, Greiner S, Russell SJ. 2008. Engineering microRNA responsiveness to decrease virus pathogenicity. Nat. Med. 14:1278-1283.
8. Leber MF, Bossow S, Leonard VH, Zaoui K, Grossardt C, Frenzke M, Miest T, Sawall S, Cattaneo R, von Kalle C, Ungerechts G. 2011. MicroRNA-sensitive oncolytic measles viruses for cancer-specific vector tropism. Mol. Ther. 19:1097-1106.
9. Lee CY, Rennie PS, Jia WW. 2009. MicroRNA regulation of oncolytic herpes simplex virus-1 for selective killing of prostate cancer cells. Clin. Cancer Res. 15:5126-5135.
10. Ylösmäki E, Hakkarainen T, Hemminki A, Visakorpi T, Andino R, Saksela K. 2008. Generation of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific MicroRNA. J. Virol. 82:11009-11015.
11. Santagati MG, Määttä JA, Itäranta PV, Salmi AA, Hinkkanen AE. 1995. The Semliki Forest virus E2 gene as a virulence determinant. J. Gen. Virol. 76(Pt 1):47-52.
12. Bradish CJ, Allner K, Maber HB. 1971. The virulence of original and derived strains of Semliki Forest virus for mice, guinea-pigs and rabbits. J. Gen. Virol. 12:141-160.
13. Fazakerley JK, Pathak S, Scallan M, Amor S, Dyson H. 1993. Replication of the A7(74) strain of Semliki Forest virus is restricted in neurons. Virology 195:627-637.
14. Mathiot CC, Grimaud G, Garry P, Bouquety JC, Mada A, Daguisy AM, Georges AJ. 1990. An outbreak of human Semliki Forest virus infections in Central African Republic. Am. J. Trop. Med. Hyg. 42:386-393.
15. Strauss JH, Strauss EG. 1994. The alphaviruses: gene expression, replication, and evolution. Microbiol. Rev. 58:491-562.
16. Willems WR, Kaluza G, Boschek CB, Bauer H, Hager H, Schutz HJ, Feistner H. 1979. Semliki Forest virus: cause of a fatal case of human encephalitis. Science 203:1127-1129.
17. Ketola A, Hinkkanen A, Yongabi F, Furu P, Määttä AM, Liimatainen T, Pirinen R, Björn M, Hakkarainen T, Mäkinen K, Wahlfors J, Pellinen R. 2008. Oncolytic Semliki Forest virus vector as a novel candidate against unresectable osteosarcoma. Cancer Res. 68:8342-8350.
18. Määttä AM, Mäkinen K, Ketola A, Liimatainen T, Yongabi FN, Vähä-Koskela M, Pirinen R, Rautsi O, Pellinen R, Hinkkanen A, Wahlfors J. 2008. Replication competent Semliki Forest virus prolongs survival in experimental lung cancer. Int. J. Cancer 123:1704-1711.
19. Vähä-Koskela MJ, Kallio JP, Jansson LC, Heikkilä JE, Zakhartchenko VA, Kallajoki MA, Kähäri VM, Hinkkanen AE. 2006. Oncolytic capacity of attenuated replicative Semliki Forest virus in human melanoma xenografts in severe combined immunodeficient mice. Cancer Res. 66:7185-7194.
20. Heikkilä JE, Vähä-Koskela MJ, Ruotsalainen JJ, Martikainen MW, Stanford MM, McCart JA, Bell JC, Hinkkanen AE. 2010. Intravenously administered alphavirus vector VA7 eradicates orthotopic human glioma xenografts in nude mice. PLoS One 5:e8603. doi:10.1371/ journal.pone.0008603.
21. Vähä-Koskela MJ, Tuittila MT, Nygårdas PT, Nyman JK, Ehrengruber MU, Renggli M, Hinkkanen AE. 2003. A novel neurotropic expression vector based on the avirulent A7(74) strain of Semliki Forest virus. J. Neurovirol. 9:1-15.
22. Sedensky MM, Hudson SJ, Everson B, Morgan PG. 1994. Identification of a mariner-like repetitive sequence in C. elegans. Nucleic Acids Res. 22:1719-1723.
23. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T. 2002. Identification of tissue-specific microRNAs from mouse. Curr. Biol. 12:735-739.
24. Chang J, Nicolas E, Marks D, Sander C, Lerro A, Buendia MA, Xu C, Mason WS, Moloshok T, Bort R, Zaret KS, Taylor JM. 2004. miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol. 1:106-113.
25. Cawood R, Chen HH, Carroll F, Bazan-Peregrino M, van Rooijen N, Seymour LW. 2009. Use of tissue-specific microRNA to control pathology of wild-type adenovirus without attenuation of its ability to kill cancer cells. PLoS Pathog. 5:e1000440. doi:10.1371/journal.ppat.1000440.
26. Tian W, Dong X, Liu X, Wang G, Dong Z, Shen W, Zheng G, Lu J, Chen J, Wang Y, Wu Z, Wu X. 2012. High-throughput functional microRNAs profiling by recombinant AAV-based microRNA sensor arrays. PLoS One 7:e29551. doi:10.1371/journal.pone.0029551.
27. Tuittila M, Nygårdas, Hinkkanen A. 2004. mRNA expression of proinflammatory cytokines in mouse CNS correlates with replication rate of Semliki Forest virus but not with the strain of viral proteins. Viral Immunol. 17:287-297.
28. Kamrud KI, Coffield VM, Owens G, Goodman C, Alterson K, Custer M, Murphy MA, Lewis W, Timberlake S, Wansley EK, Berglund P, Smith J. 2010. In vitro and in vivo characterization of microRNA-targeted alphavirus replicon and helper RNAs. J. Virol. 84:7713-7725.
29. Deo M, Yu JY, Chung KH, Tippens M, Turner DL. 2006. Detection of mammalian microRNA expression by in situ hybridization with RNA oligonucleotides. Dev. Dyn. 235:2538-2548.
30. Pena JT, Sohn-Lee C, Rouhanifard SH, Ludwig J, Hafner M, Mihailovic A, Lim C, Holoch D, Berninger P, Zavolan M, Tuschl T. 2009. miRNA in situ hybridization in formaldehyde and EDC-fixed tissues. Nat. Methods 6:139~-141. doi:10.1038/nmeth.1294.
31. Fazakerley JK, Cotterill CL, Lee G, Graham A. 2006. Virus tropism, distribution, persistence and pathology in the corpus callosum of the Semliki Forest virus-infected mouse brain: a novel system to study virus-oligodendrocyte interactions. Neuropathol. Appl. Neurobiol. 32:397-409.
32. Deuber SA, Pavlovic J. 2007. Virulence of a mouse-adapted Semliki Forest virus strain is associated with reduced susceptibility to interferon. J. Gen. Virol. 88:1952-1959.
33. Ruotsalainen J, Martikainen M, Niittykoski M, Huhtala T, Aaltonen T, Heikkilä J, Bell J, Vähä-Koskela M, Hinkkanen A. 2012. Interferon-beta sensitivity of tumor cells correlates with poor response to VA7 virotherapy in mouse glioma models. Mol. Ther. doi:10.1038/mt.2012.53.